Interestingly, recent studies have suggested that PDE5 inhibitors may be beneficial in treating the patients with hypertension, cardiovascular diseases, diabetes, CNS-related diseases, or cancers [3–5]. This evidence concerns the gene PDE5A and diabetes mellitus.